Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Industry Insights
  • Page 6

Category: Industry Insights

Get the latest industry insights and trends in the pharmaceutical sector with Med Pharma News. Stay informed about groundbreaking research, regulatory updates, and market analysis.

Graphic: hospital EBITDA impact shown as three bars with one reduced segment
  • Industry Insights

Hospital EBITDA Impact: India’s Cancer Drug Margin Cap

Megan Wood4 weeks ago011 mins

Hospital EBITDA impact of India’s 30% cancer drug margin cap: the estimate, assumptions to question and key dates, 27 October and 9 November.

Read More
Graphic: Indian hospital IPOs shown as rising bars with a highlighted marker
  • Industry Insights

Indian Hospital IPOs: Paras Health Issue in Context

Megan Wood4 weeks ago4 weeks ago010 mins

Indian hospital IPOs: Paras Health’s ₹1,450 crore issue, debt-repayment plan, anchor round and expansion, with risks and open questions.

Read More
Graphic: OpenAI life sciences AI shown as a faceted badge with a central node
  • Industry Insights

OpenAI Life Sciences AI: Orchestra Bio Deal and Rosalind

Megan Wood4 weeks ago4 weeks ago012 mins

OpenAI life sciences AI adds Orchestra Bio’s R&D coordination team. What Rosalind covers, what was not disclosed and what to watch.

Read More
Graphic: Ebola outbreak Africa shown as a line of spreading points ending at Nigeria
  • Industry Insights

Ebola Outbreak Africa: Nigeria Becomes Fifth Country

Megan Wood4 weeks ago4 weeks ago011 mins

Ebola outbreak Africa update: Nigeria confirms an imported case in Abuja, the fifth country affected. What WHO says and what is still unknown.

Read More
Graphic: GLP-1 beauty market shown as a rising trend line
  • Industry Insights

GLP-1 Beauty Market: Brands Test Skin-Change Products

Megan Wood4 weeks ago4 weeks ago012 mins

GLP-1 beauty market: L’Oréal, Natura and Galderma are testing products for weight-loss skin changes. See the forecasts and open questions.

Read More
Graphic: biotechnology IPO 2026 showing a stack of gold and purple coins for the Lycia raise
  • Industry Insights

Biotechnology IPO 2026: Lycia Eyes $265M, Faces Big Risks

Megan Wood4 weeks ago4 weeks ago010 mins

Biotechnology IPO 2026: Lycia Therapeutics eyes up to $264.6M. What the money funds, the runway and the risks in the filing.

Read More
Graphic: Maharashtra FDA hospital inspection with linked chain rings showing contractor oversight
  • Industry Insights

Maharashtra FDA Hospital Inspection: Vendor Risk Exposed

Megan Wood4 weeks ago4 weeks ago011 mins

Maharashtra FDA hospital inspection: the Fortis Mulund kitchen suspension and what it means for outsourced hospital services.

Read More
Graphic: Bundibugyo virus outbreak with a crossed-out vaccine vial showing no approved vaccine
  • Industry Insights

Bundibugyo Virus Outbreak: No Vaccine Raises Alarm

Megan Wood4 weeks ago010 mins

Bundibugyo virus outbreak: no approved vaccine or treatment as the DR Congo epidemic reaches an eighth province. What trials are under way.

Read More
Graphic: Labcorp OPKO Health deal, $722 million for select BioReference assets and more than 80 patient service centres
  • Industry Insights

Labcorp Bets on Lab Consolidation With OPKO Health Deal

Megan Wood1 month ago1 month ago010 mins

Labcorp OPKO Health deal: $722M cash plus up to $150M for select BioReference assets. The economics, the logic and what could still change.

Read More
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 40

Categories

  • Healthcare IT (26)
  • Industry Insights (355)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (105)
  • Uncategorized (1)

Recent Posts

  • Teva Price-Fixing Settlement: 45 States Strike Deal in Generic Drug Collusion Case
  • Gedeon Richter Mayne Pharma Deal: A$604M Buys a US Women’s Health Platform
  • Lilly Stipple Bio Deal: Why Eli Lilly Is Betting Up to $5.9B on Tumor-Only Targets
  • Lilly Calytrix Acquisition: $1.5B Bet on a Blood Cancer Mutation
  • J&J Ollin Acquisition: $2.2B Bet on an Eye Drug Built to Beat Vabysmo
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.